Impulsive and compulsive behaviors have become increasingly associated with Parkinson disease (PD) and treatment. Recently, the International Parkinson’s and Movement Disorder Society commissioned a task force to assess currently available screening tools and rating scales in order to make recommendations regarding their utility, as well as to inform future directions in scale development and validation.
Impulsive and compulsive behaviors (ICBs) have become increasingly associated with Parkinson disease (PD) and treatment. Recently, the International Parkinson’s and Movement Disorder Society commissioned a task force to assess currently available screening tools and rating scales in order to make recommendations regarding their utility, as well as to inform future directions in scale development and validation.
Members of the task force conducted a systematic review on available screening tools and scales used in PD studies to detect a range of impulse control disorders (ICDs), including compulsive medication use, pathological gambling, hypersexuality, binge eating, and reckless driving, among others.
The group identified 50 scales used to measure the severity of ICDs in studies of patients with PD. Study investigators assessed each scale for descriptive and clinometric properties, availability content, use, acceptability, and overall impression in patients with PD. The group recommended a scale if it had been applied to PD populations, contained data on the use of the scale in more than 1 cohort, and if the scale was determined as adequate for either screening purposes, assessing symptom severity, or measuring responsiveness to change.
The group reached a few recommendations on which scale to use:
The study authors suggest that early identification of ICDs can help guide treatment decisions in patients with PD, as the presence of multiple ICDs in this population may be associated with poorer quality of life, depression, or treatment resistance. Going forward, the researchers recommend that “further testing of established scales against gold standard diagnostic criteria is urgently required for all other individual ICBs in PD,” wrote the authors.
Reference
Evans A, Okai D, Weintraub D, et al. Members of the International Parkinson and Movement Disorder Society (IPMDS) rating scales review committee. Scales to assess impulsive and compulsive behaviors in Parkinson’s disease: critique and recommendations. Mov Disord. 2019;34(6):791-798.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Real-World Data Support Safety, Efficacy of Venetoclax for CLL
August 29th 2025A single-center study comparing patients with chronic lymphocytic leukemia receiving venetoclax as part of a clinical trial and patients receiving it in routine clinical practice showed very high complete response rates in both groups.
Read More
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen